1. Home
  2. VIAV vs IOVA Comparison

VIAV vs IOVA Comparison

Compare VIAV & IOVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VIAV
  • IOVA
  • Stock Information
  • Founded
  • VIAV 1923
  • IOVA 2007
  • Country
  • VIAV United States
  • IOVA United States
  • Employees
  • VIAV N/A
  • IOVA N/A
  • Industry
  • VIAV Semiconductors
  • IOVA Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • VIAV Technology
  • IOVA Health Care
  • Exchange
  • VIAV Nasdaq
  • IOVA Nasdaq
  • Market Cap
  • VIAV 2.3B
  • IOVA 975.1M
  • IPO Year
  • VIAV 1993
  • IOVA N/A
  • Fundamental
  • Price
  • VIAV $12.17
  • IOVA $2.30
  • Analyst Decision
  • VIAV Buy
  • IOVA Buy
  • Analyst Count
  • VIAV 8
  • IOVA 11
  • Target Price
  • VIAV $13.10
  • IOVA $11.90
  • AVG Volume (30 Days)
  • VIAV 3.1M
  • IOVA 10.8M
  • Earning Date
  • VIAV 10-30-2025
  • IOVA 11-06-2025
  • Dividend Yield
  • VIAV N/A
  • IOVA N/A
  • EPS Growth
  • VIAV N/A
  • IOVA N/A
  • EPS
  • VIAV 0.15
  • IOVA N/A
  • Revenue
  • VIAV $1,084,300,000.00
  • IOVA $241,525,000.00
  • Revenue This Year
  • VIAV $12.24
  • IOVA $67.40
  • Revenue Next Year
  • VIAV $4.11
  • IOVA $56.32
  • P/E Ratio
  • VIAV $80.63
  • IOVA N/A
  • Revenue Growth
  • VIAV 8.39
  • IOVA 636.99
  • 52 Week Low
  • VIAV $8.10
  • IOVA $1.64
  • 52 Week High
  • VIAV $12.91
  • IOVA $12.51
  • Technical
  • Relative Strength Index (RSI)
  • VIAV 72.71
  • IOVA 50.67
  • Support Level
  • VIAV $11.54
  • IOVA N/A
  • Resistance Level
  • VIAV $12.28
  • IOVA $2.46
  • Average True Range (ATR)
  • VIAV 0.24
  • IOVA 0.14
  • MACD
  • VIAV 0.04
  • IOVA -0.09
  • Stochastic Oscillator
  • VIAV 90.76
  • IOVA 92.00

About VIAV Viavi Solutions Inc.

Viavi Solutions Inc. is an international provider of network test, monitoring, and assurance solutions to communications service providers, enterprises, network equipment manufacturers, civil government, military and avionics customers. The company also offers high-performance thin-film optical coatings, providing light management solutions to anti-counterfeiting, 3D sensing, electronics, automotive, defense, and instrumentation markets. Its operating segments include Network Enablement, Service Enablement, and Optical Security and Performance Products. Geographically, it derives a majority of its revenue from the United States. Additionally, it manufactures and sells optical filters for 3D sensing products that allow facial recognition security authentication for mobile devices.

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.

Share on Social Networks: